Skip to content
Home/Companies/Biotech/Pieris

Pieris

Biotech·United States·Exited 2014·Held 1yr
Entry
2013
Hold
1yr
Exit
2014

Who owns Pieris?

Pieris was owned by Sobera Capital through Sobera Capital Fund II (2013 vintage) from 2013 to 2014, exited via IPO.

Hand-verified · updated 2026-08-10

Sobera Capital
Investor
Sobera Capital
Sobera Capital Fund II · 2013 · Secondaries

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2014

More from Sobera Capital Fund II

Other portfolio companies in the same fund.

OneAccess Networks
Exited 2017
TelecomFrance· 2013
to

More Sobera Capital portfolio companies

From the same investor, across funds.

Cortus
Cortus
Active
Deep TechFrance· 2020
salveco
salveco
Exited 2021
ConsumerFrance· 2020
to
Axellis
Exited 2022
MedTechUnited Kingdom· 2018
EffRx Pharmaceuticals
EffRx Pharmaceuticals
Exited 2023
PharmaSwitzerland· 2018
to
M.O.R.E Medical Solutions
Active
MedTechGermany· 2018
Memo Therapeutics
Memo Therapeutics
Exited 2026
BiotechSwitzerland· 2018
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Pieris

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Pieris.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue